Benjamin Graham fit · Investissement defensive deep-value
Is Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) a Benjamin Graham Stock?
Meets only 4/7 Graham criteria — likely overpriced or unstable.
13/100
FPas un fit
4/7 critères validés
Les critères de Benjamin Graham, appliqués à AMRX
P/E ≤ 15
clé—
P/B ≤ 1.5
clé0.0x
Current ratio ≥ 2
2.1x
Debt / Equity ≤ 1
0.0x
Comment AMRX se classe selon d'autres stratégies
Données financières en direct
Cap. boursière
$4.21B
PER (TTM)
-
ROIC (TTM)
9.19%
Marge brute
36.76%
Questions fréquentes
What is AMRX's Benjamin Graham fit score?
AMRX scores 13/100 on our Benjamin Graham fit engine — grade F. Meets only 4/7 Graham criteria — likely overpriced or unstable.
Does Benjamin Graham actually own AMRX?
Our score is computed from financial fundamentals against Benjamin Graham's published criteria. We don't claim that Benjamin Graham personally owns or recommends AMRX.
How often is this score updated?
AMRX's Benjamin Graham fit score is recomputed daily from the latest TTM financials.
Outil éducatif, pas un conseil en investissement. Les scores sont calculés à partir de données financières publiques selon les critères publiés de chaque stratégie d'investissement. Nous ne prétendons pas que Benjamin Graham possède ou recommande AMRX personnellement.